Jamie Howard, NP
Family · Scottsdale, AZNPI 1174132369
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,858 of the $14,489 with a category attached, or 74.9%. 19 manufacturers reported payments, led by Medtronic at 28.3% of the total. Reporting peaked in 2022 at $4,473 and has fallen 81.7% since, to $819 in 2025. Among family clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $66.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$4K
- Atricure, Inc.$2K
- Cvrx, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$615
- Kestra Medical Technology Services, Inc.$514
- plus $2K from 13 others
Across 5 payments — averaging $290.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
What the payments were for
- Travel & lodging$3,63225%
- Food & beverage$10,85875%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 41 | $4,104 |
| Abbott | 87 | $3,995 |
| Atricure, Inc. | 8 | $1,693 |
| Cvrx, Inc. | 24 | $1,304 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $615 |
| Kestra Medical Technology Services, Inc. | 7 | $514 |
| Boston Scientific | 7 | $405 |
| Abiomed | 3 | $402 |
| Itamar Medical Inc | 3 | $251 |
| Impulse Dynamics (USA) Inc. | 2 | $247 |
| Philips North America LLC | 2 | $218 |
| Sanofi-aventis U.S. LLC | 5 | $182 |
| ZOLL Respicardia, Inc. | 1 | $179 |
| AstraZeneca | 1 | $125 |
| Inspire Medical Systems, Inc. | 1 | $117 |
| Johnson & Johnson | 4 | $61 |
| Biosense Webster, Inc. | 2 | $50 |
| Pfizer | 1 | $16 |
| Preventice Services, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,424
- Micra$1,106
- Barostim Neo System$1,021
- LINQ II$758
- AVEIR$754
- Assure WCD$394
- CARDIOMEMS$360
- ASSURITY$318
- OPTIMIZER$278
- Impella$272
- Assurity Pacemaker$259
- NA$186
- remede System$179
- SYNERGY ABLATION SYSTEM$154
- WatchPat$152
- (AM5) Lead management$134
- CryoConsole$130
- GALLANT$128
- Inspire Upper Airway Stimulation System$117
- WATCHMAN Access System$117
How this compares
$14,489 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 212 | $225,900 |
| XareltoRivaroxaban | 51 | $49,626 |
| MultaqDronedarone Hcl | 40 | $45,383 |
| Dofetilide | 81 | $9,670 |
| Amiodarone Hcl | 145 | $3,468 |
| Metoprolol Succinate | 218 | $3,275 |
| Flecainide Acetate | 99 | $3,228 |
| Mexiletine Hcl | 15 | $1,704 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 37 | $1,356 |
| SotalolSotalol Hcl | 87 | $1,268 |
| Diltiazem 24hr ErDiltiazem Hcl | 21 | $537 |
| ClopidogrelClopidogrel Bisulfate | 32 | $421 |
| Verapamil ErVerapamil Hcl | 14 | $262 |
| Tiadylt ErDiltiazem Hcl | 12 | $203 |
| Metoprolol Tartrate | 38 | $196 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $16 | $225,900212 claims |
| Johnson & JohnsonXarelto | $61 | $49,62651 claims |
| Sanofi-aventis U.S. LLCMultaq | $182 | $45,38340 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,119 family providers in Arizona.
Other family in Scottsdale
- Kaitlyn LouchheimScottsdale$208K
- Jennifer PrinceScottsdale$76K
- Camilla BinksScottsdale$62K
- Jessica TapiaScottsdale$36K
- Dawn MougelScottsdale$34K
- Keegan RussellScottsdale$28K
- Anna CramerScottsdale$14K
- Sharon MagalonaMesa$441K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.